Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Gozzetti

Showing results (111-120 of 212) with videos related to

Pageof 22
Sort By:
Cancer Genetics and Cytogenetics|August 1, 2006
Trisomy 22 as sole cytogenetic abnormality in acute monoblastic leukemia (M5b)Alessandro Gozzetti, Simona Calabrese, Rosaria Crupi, et al.
Vaccines|February 26, 2022
Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA VaccineClaudia Gandolfo, Gabriele Anichini, Marco Mugnaini, et al.
Haematologica|November 5, 2002
CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcomeDonatella Raspadori, Daniela Damiani, Mariagrazia Michieli, et al.
Hematological Oncology|January 4, 2007
The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotypeDaniela Damiani, Mario Tiribelli, Donatella Raspadori, et al.
Frontiers in Oncology|January 8, 2021
Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma PatientsAlessandro Gozzetti, Francesca Bacchiarri, Vincenzo Sammartano, et al.
Clinical and Experimental Medicine|November 18, 2023
Real-life diagnostic and therapeutic approach to CLL: a 2022 update from an expert panel in TuscanyClaudia Baratè, Alessandro Sanna, Edoardo Benedetti, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 30, 2010
Outcome and toxicity in the modern era of new drugs for multiple myeloma: a reappraisal for comparison with future investigational trialsMassimo Offidani, Pietro Leoni, Laura Corvatta, et al.
Cancer|May 16, 2007
Characterization of Ph-negative abnormal clones emerging during imatinib therapyElisabetta Abruzzese, Alessandro Gozzetti, Sara Galimberti, et al.
European Journal of Haematology|March 3, 2010
Thalidomide-dexamethasone as up-front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low-dose warfarinMichela Cini, Elena Zamagni, Lelia Valdré, et al.
Blood|September 22, 2017
Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemiaVanessa Zurli, Giuliana Wimmer, Francesca Cattaneo, et al.
Pageof 22

Showing results (111-120 of 212) with videos related to

Sort By:
Pageof 22
Cancer Genetics and Cytogenetics|August 1, 2006
Trisomy 22 as sole cytogenetic abnormality in acute monoblastic leukemia (M5b)Alessandro Gozzetti, Simona Calabrese, Rosaria Crupi, et al.
Vaccines|February 26, 2022
Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA VaccineClaudia Gandolfo, Gabriele Anichini, Marco Mugnaini, et al.
Haematologica|November 5, 2002
CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcomeDonatella Raspadori, Daniela Damiani, Mariagrazia Michieli, et al.
Hematological Oncology|January 4, 2007
The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotypeDaniela Damiani, Mario Tiribelli, Donatella Raspadori, et al.
Frontiers in Oncology|January 8, 2021
Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma PatientsAlessandro Gozzetti, Francesca Bacchiarri, Vincenzo Sammartano, et al.
Clinical and Experimental Medicine|November 18, 2023
Real-life diagnostic and therapeutic approach to CLL: a 2022 update from an expert panel in TuscanyClaudia Baratè, Alessandro Sanna, Edoardo Benedetti, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 30, 2010
Outcome and toxicity in the modern era of new drugs for multiple myeloma: a reappraisal for comparison with future investigational trialsMassimo Offidani, Pietro Leoni, Laura Corvatta, et al.
Cancer|May 16, 2007
Characterization of Ph-negative abnormal clones emerging during imatinib therapyElisabetta Abruzzese, Alessandro Gozzetti, Sara Galimberti, et al.
European Journal of Haematology|March 3, 2010
Thalidomide-dexamethasone as up-front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low-dose warfarinMichela Cini, Elena Zamagni, Lelia Valdré, et al.
Blood|September 22, 2017
Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemiaVanessa Zurli, Giuliana Wimmer, Francesca Cattaneo, et al.
Pageof 22